Viela Bio, Inc. reported unaudited earnings results for the second quarter and six months ended June 30, 2020. For the quarter, the company reported loss from operations of $39,820,000 against $6,107,000 a year ago. Net loss was $38,857,000 or $0.74 per basic and diluted share against $5,473,000 or $8.94 per basic and diluted share a year ago. For the six months, the company reported loss from operations of $81,931,000 against $27,759,000 a year ago. Net loss was $79,634,000 or $1.55 per basic and diluted share against $26,449,000 or $72.06 per basic and diluted share a year ago.